Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

PHASE4CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Essential Hypertension
Interventions
DRUG

Aliskiren

Aliskiren supplied in 150 mg and 300 mg tablets.

DRUG

Placebo to Aliskiren

Placebo to Aliskiren matching 150 and 300 mg tablets

Trial Locations (3)

Unknown

Investigative Site, Zanesville

Investigative Site, Frankfurt

Investigative Site, Valencia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY